IIM
TXG icon

INTECH Investment Management’s 10x Genomics TXG Stock Holding History

INTECH Investment Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Buy
26,839
+778
+3% +$20.4K 0.01% 1014
2026
Q1 		$553K Sell
26,061
-13,986
-35% -$280K 0.01% 1291
2025
Q4 		$653K Buy
40,047
+567
+1% +$8.56K 0.01% 1359
2025
Q3 		$462K Sell
39,480
-13,471
-25% -$176K ﹤0.01% 1619
2025
Q2 		$613K Buy
52,951
+30,850
+140% +$281K 0.01% 1483
2025
Q1 		$193K Buy
+22,101
New +$279K ﹤0.01% 2106

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

INTECH Investment Management's TXG Position: Q2 2026 in Review

INTECH Investment Management increased its 10x Genomics (TXG) stake by 3% in Q2 2026, buying an estimated $20.4K and bringing the position to 26,839 shares worth $1.03M. The position accounts for 0.01% of the portfolio, ranked #1014.

INTECH Investment Management first reported a position in TXG in Q1 2025 and has held it in 6 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • INTECH Investment Management held 26,839 shares of 10x Genomics worth $1.03M as of Q2 2026.
  • INTECH Investment Management bought 778 10x Genomics shares in Q2 2026, an estimated $20.4K.
  • 10x Genomics made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1014 holding.
  • INTECH Investment Management first reported a position in 10x Genomics in Q1 2025 and has held it in 6 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.